Cholesterol & Lipid
Sort by:
13th Orange County Symposium for Cardiovascular Disease Prevention
Top 10 Dietary Strategies for Atherosclerotic Cardiovascular Risk Reduction
FEATURING
Geeta Sikand
- 2,977 views
- January 26, 2022
- 16
Houston Methodist DeBakey Heart and Vascular Center
Aspirin & Primary Prevention: What Do the Guidelines Say?
FEATURING
Martha Gulati
- 3,160 views
- January 25, 2022
- 13
National Lipid Association
Lessons Learned from REDUCE-IT, STRENGTH, PROMINENT; Informing Guidelines
FEATURING
Anandita Kulkarni
- 1,377 views
- October 11, 2023
- 4
National Lipid Association
Patient-Centered Lifestyle Interventions for Obesity – One Size Does Not Fit All
FEATURING
Carol F. Kirkpatrick
- 1,388 views
- October 11, 2023
- 10
The Texas Heart Institute
The Use of Coronary Artery Calcium Score to Determine Benefit of Aspirin Therapy
FEATURING
Eduardo Hernandez
- 1,136 views
- November 12, 2021
- 11
Canadian Collaborative Research Network
Approaching a Decade of PCSK9 Inhibition: Effects on CV Mortality
FEATURING
Milan Gupta
- 392 views
- July 26, 2023
- 2
Cardiovascular Atherosclerosis: Prediction, Prevention and Management
Exercise and Cardiovascular Risk
FEATURING
Christopher J. Suhar
- 572 views
- August 18, 2021
- 5
ASPC 2020 Virtual Summit on CVD Prevention
Integrating Imaging & Advanced Blood Testing for CVD Prevention/Management: How Do We Know If the Patient Is in Prediabetes Phase? Why Do Lipoproteins Become Atherogenic? What Is the Role of Non-Lifestyle Genetic Markers?
FEATURING
Arthur Agatston
- 483 views
- March 24, 2021
- 3
Complex Coronary Cases
Eliminating Coronary Artery Disease
FEATURING
Marc Sabatine
- 1,167 views
- August 31, 2023
- 10
National Lipid Association
Is Our Destiny Written for FH and Lp(a)?
FEATURING
Joshua Knowles
- 2,027 views
- October 11, 2023
- 10
Matthew Budoff
LDL Lowering and CV Risk: What to Consider When Working to Reduce Patients' LDL Cholesterol?
- 253 views
- December 3, 2020
- 1
Cleveland Clinic | 12th Annual Obesity Summit
Management of Hypertension and Hyperlipidemia in Type 2 Diabetes
FEATURING
Steven Nissen
- 2,151 views
- December 3, 2017
- 8
Advances in Cardiovascular Disease Prevention
Paradigm Shifts: Understanding and Applying the Latest Lipid Guidelines
FEATURING
Andrew Freeman
- 1,336 views
- October 22, 2018
- 6
Complex Coronary Valvular and Vascular Cases Conference
Can Coronary Artery Disease Be Eliminated In Our Lifetime?
- 1,166 views
- November 14, 2017
- 7
Naveed Sattar
Can Empagliflozin Successfully Treat T2D Whilst Preventing Heart Failure and Protecting Renal Function?
- 819 views
- November 25, 2020
- 3
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Novelties in Lipid Lowering Therapies: Can Statin Therapy Reduce Residual Risk? How Promising Are Icosapent Ethyl, Bampedoic Acid, Inclisiran and Evinacumab for Treating the Patients?
FEATURING
Pam Taub
- 919 views
- February 5, 2021
- 10
Cardiometabolic Health Congress (CMHC)
ASCVD Risk Assessment and Prevention: Where Do We Stand Now?
FEATURING
Salim Virani
- 1,164 views
- July 23, 2022
- 13
ASPC 2019 Congress on CVD Prevention
Unraveling the Mysteries of Heart Disease: Lessons from the 70 Year Legacy of the Framingham Heart Study
FEATURING
Daniel Levy
- 393 views
- August 9, 2019
- 3
Houston Methodist DeBakey Heart and Vascular Center
Power of Zero: Shaping Past, Present and Future of Cardiovascular Risk Assessment & Management
FEATURING
Khurram Nasir
- 846 views
- October 28, 2022
- 2
National Lipid Association
Preventative Healthcare for Children with Dyslipidemia - Unique Opportunities and Challenges
FEATURING
Amy Peterson
- 394 views
- March 25, 2019
- 1
ASPC 2018 Congress on CVD Prevention
Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Higher CVD Risk
FEATURING
Patrick Moriarty
- 833 views
- August 10, 2018
- 10
National Lipid Association
The Ketogenic Diet - Where Does the Evidence Stand for ASCVD risk?
FEATURING
Carol Kirkpatrick
- 3,854 views
- March 25, 2019
- 19